(2S)-2-((S)-2-amino-3-phenylpropanamido)-2-((2S,4R,5R,6R)-6-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)acetic acid

ID: ALA5269429

Max Phase: Preclinical

Molecular Formula: C20H24N4O8

Molecular Weight: 448.43

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)[C@@H]1C[C@@H](O)[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O1

Standard InChI:  InChI=1S/C20H24N4O8/c21-11(8-10-4-2-1-3-5-10)17(28)23-15(19(29)30)13-9-12(25)16(27)18(32-13)24-7-6-14(26)22-20(24)31/h1-7,11-13,15-16,18,25,27H,8-9,21H2,(H,23,28)(H,29,30)(H,22,26,31)/t11-,12+,13-,15-,16+,18+/m0/s1

Standard InChI Key:  MZWYEBXQQMOLTC-QGJUDNFOSA-N

Molfile:  

 
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    3.5727   -0.6185    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5727    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2872    0.6189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2872    1.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0017    1.8564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5727    1.8564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8583    1.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8583    0.6189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1437    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1437   -0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8583   -1.0313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4291   -1.0314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4291   -1.8564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144   -0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4291    0.6190    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1310   -0.3769    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0000    0.6189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0000    1.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144    1.8564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145    1.8564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145    0.2064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4289    0.6189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4289    1.4439    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1435    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1435   -0.6185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8579    0.6189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5724    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5727   -0.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2854   -1.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0000   -0.6166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0017    0.2043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2900    0.6206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  8  7  1  0
  8  2  1  0
  9  8  1  1
 10  9  1  0
 10 11  1  6
 12 10  1  0
 12 13  1  6
 14 12  1  0
 15 14  1  0
 15 16  1  0
  9 16  1  0
 15 17  1  6
 15 18  1  0
 18 19  1  6
 19 20  1  0
 19 21  2  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  0
 29 28  2  0
 30 29  1  0
 31 30  2  0
 32 31  1  0
 33 32  2  0
 28 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5269429

    ---

Associated Targets(non-human)

Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coccidioides immitis (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.43Molecular Weight (Monoisotopic): 448.1594AlogP: -2.31#Rotatable Bonds: 7
Polar Surface Area: 196.97Molecular Species: ACIDHBA: 9HBD: 6
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.59CX Basic pKa: 8.00CX LogP: -3.92CX LogD: -4.01
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.27Np Likeness Score: 0.71

References

1. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

Source